A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
Bristol-Myers Squibb
Bristol-Myers Squibb
Institut Bergonié
Bristol-Myers Squibb
GlaxoSmithKline
Inspirna, Inc.
Intensity Therapeutics, Inc.
Anaveon AG
Herlev Hospital
Herlev and Gentofte Hospital
Oslo University Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sumitomo Pharma America, Inc.
Jounce Therapeutics, Inc.
SQZ Biotechnologies
Constellation Pharmaceuticals
Pfizer
University of California, San Francisco
NYU Langone Health
M.D. Anderson Cancer Center
Lytix Biopharma AS
Bristol-Myers Squibb
Bristol-Myers Squibb
National Cancer Institute (NCI)